Clinical Trial: TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation

Study Status: Completed
Recruit Status: Unknown status
Study Type: Observational

Official Title: Therapeutic Angiogenesis Using Cell Transplantation (TACT) Study at Nagoya

Brief Summary: Clinical studies have established that implantation of bone marrow mononuclear cells (BM-MNCs) or peripheral blood mononuclear cells (PB-MNCs) into ischaemic limbs increases collateral vessel formation. We, the investigators at Nagoya University, further investigated the efficacy and safety of autologous implantation of BM-MNCs or PB-MNCs in patients with severe ischaemic limbs who have no other alternative therapeutic options. We also examined a potential limiting factor which reduced the efficacy of therapeutic angiogenesis using cell transplantation (TACT).

Detailed Summary:
Sponsor: Nagoya University

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Nagoya University

Dates:
Date Received: September 2, 2005
Date Started: August 2003
Date Completion:
Last Updated: December 29, 2005
Last Verified: August 2003